Shenzhen Grandway Capital Management

Shenzhen Grandway Capital Management, commonly known as Grandway Capital, is a prominent Chinese venture capital and private equity firm specializing in the healthcare and life sciences sectors. Headquartered in Shenzhen, the firm focuses on identifying high-potential startups and growth-stage companies involved in innovative drug discovery, medical technology, and digital health. Grandway Capital provides strategic capital and industry expertise to help its portfolio companies navigate clinical development and market entry in China. The firm has a track record of investing in successful biotechnology companies such as InnoCare Pharma, ImmuneOnco, and Antengene. Its investment strategy emphasizes scientific innovation and unmet medical needs within the Chinese healthcare market.